| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-0142(19990401)85:7<1599::AID-CNCR23>3.3.CO;2-R |
| P698 | PubMed publication ID | 10193952 |
| P2093 | author name string | Tonato M | |
| Carlini P | |||
| Di Costanzo F | |||
| Boni C | |||
| Cocconi G | |||
| Di Sarra S | |||
| Fosser V | |||
| Franciosi V | |||
| Michiara M | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast carcinoma | Q18555947 |
| lung carcinoma | Q18556110 | ||
| cisplatin | Q412415 | ||
| etoposide | Q418817 | ||
| chemotherapy | Q974135 | ||
| P304 | page(s) | 1599-1605 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study | |
| P478 | volume | 85 |
| Q37172818 | A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases |
| Q33339923 | A phase II trial of temozolomide for patients with recurrent or progressive brain metastases |
| Q34566440 | Advances in stereotactic radiosurgery for brain neoplasms |
| Q57176317 | Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine |
| Q37036930 | Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features |
| Q74267156 | Brain metastases |
| Q43892139 | Brain metastases from fallopian tube carcinoma responsive to intra-arterial carboplatin and intravenous etoposide: a case report |
| Q51193862 | Brain metastases research 1990-2010: pattern of citation and systematic review of highly cited articles. |
| Q38317417 | Brain metastases: an overview |
| Q34626909 | Brain metastases: treatment options to improve outcomes |
| Q38222247 | Brain metastasis: new opportunities to tackle therapeutic resistance |
| Q37698300 | Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guideline. |
| Q36822500 | Breast cancer brain metastases: new directions in systemic therapy |
| Q26775663 | Breast cancer brain metastases: the last frontier |
| Q36853533 | CNS complications of breast cancer: current and emerging treatment options |
| Q47185642 | Cancer Chemotherapy Update: Bevacizumab, Etoposide, and Cisplatin Regimen for Refractory Brain Metastases |
| Q33595274 | Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study |
| Q34014740 | Central nervous system cancers |
| Q37328281 | Cerebral metastases from malignant melanoma: current treatment strategies, advances in novel therapeutics and future directions. |
| Q58297721 | Chemotherapy in brain metastases of lung and breast cancer |
| Q48806386 | Clinical trial design in brain metastasis: approaches for a unique patient population |
| Q26752378 | Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis |
| Q33475484 | Current management of metastatic brain disease |
| Q33386298 | Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study. |
| Q26824799 | Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer |
| Q38763111 | Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future |
| Q34872345 | Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors |
| Q54118354 | Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases. |
| Q38688750 | Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG). |
| Q87597521 | Leptomeningeal Metastases |
| Q37303869 | New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer |
| Q37643566 | Oligometastatic non-small-cell lung cancer: current treatment strategies |
| Q90458957 | Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers |
| Q28072442 | Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases |
| Q37641250 | Phase II trial of patupilone in patients with brain metastases from breast cancer |
| Q42362521 | Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System |
| Q33224924 | Radiotherapy and chemotherapy of brain metastases |
| Q30814798 | Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guideline. |
| Q38985340 | State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancer |
| Q38285931 | Systemic therapy of brain metastases. |
| Q30239901 | Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma |
| Q37727648 | Systemic treatment of non-small cell lung cancer brain metastases |
| Q38715328 | Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors |
| Q33365077 | Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study |
| Q33368201 | Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases |
| Q37586262 | The role of chemotherapy in the treatment of patients with brain metastases from solid tumors |
| Q53827061 | Treatment of Brain Metastases. |
| Q36057858 | Treatment of Breast Cancer Brain Metastases |
| Q90688022 | Tyrosine Kinase Inhibitor Therapy for Brain Metastases in Non-Small-Cell Lung Cancer: A Primer for Radiologists |
Search more.